Test Price
2,800 AED✅ Home Collection Available
RET Gene Multiple Endocrine Neoplasia Type 2B (MEN2B) Genetic Test in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO-accredited next-generation sequencing for full-gene RET analysis.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Post-Test Guidance: Telephonic genetic counselling and result interpretation provided by a Consultant Medical Genetics specialist.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
- Regulatory Compliance: Fully aligned with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields.
Test Overview & Methodology
This advanced genetic test employs full-gene next-generation sequencing (NGS) to interrogate the entire RET gene for pathogenic variants associated with Multiple Endocrine Neoplasia Type 2B (MEN2B). MEN2B is a hereditary syndrome that predisposes individuals to medullary thyroid carcinoma and pheochromocytoma. Early molecular diagnosis enables proactive surveillance, prophylactic thyroidectomy planning, and lifelong risk management, aligning with Dubai Health Authority precision medicine initiatives.
| Feature | Our RET MEN2B NGS Test | Closest Alternative (Targeted Panel) |
|---|---|---|
| Precision (Analytical Sensitivity) | 99.9% – detects rare and novel variants across entire RET gene | ~95% – limited to common hotspot mutations only |
| Methodology | Full-gene Next Generation Sequencing (NGS) with bioinformatics variant calling | Sanger sequencing or multiplex PCR targeting known SNPs |
| Turnaround Time | 3–4 Weeks | 2–3 Weeks |
| Variant Detection Scope | All coding exons, splice sites, and known regulatory regions | Pre-selected common variants only |
Physician Insight & Safety Protocols
"Receiving a positive RET mutation result understandably raises many concerns, yet early molecular confirmation equips families with actionable surveillance strategies and the opportunity for prophylactic thyroidectomy, substantially reducing lifetime cancer risk. Our dedicated genetic counsellors provide structured support throughout the diagnostic journey to ensure every patient understands their result and the recommended clinical pathway."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre-Test Genetic Counselling Advisory
Prior to sample collection, a mandatory pre-test genetic counselling session is conducted to review family history, discuss potential implications of positive, negative, and variant of uncertain significance (VUS) results, and obtain written informed consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Patients are encouraged to involve a first-degree relative during counselling for shared decision-making.
Exclusion Criteria & Clinical Red Flags
- Exclusion Criteria: Individuals under 18 years without a valid court order per UAE personal status regulations; inability to provide written informed consent after counselling; acute febrile illness or active infection that may compromise sample integrity.
- Emergency Red Flags: Sudden severe headache, palpitations, diaphoresis, or hypertensive urgency within hours of blood draw may indicate pheochromocytoma crisis. Patients with known or suspected MEN2B who experience these symptoms should seek immediate emergency medical attention.
Patient FAQ & Clinical Guidance
1. What is the RET gene MEN2B test and why is it recommended?
This test uses next-generation sequencing to analyze the complete RET gene for mutations that cause Multiple Endocrine Neoplasia Type 2B. It is recommended for individuals with a family history of MEN2B, characteristic clinical features such as mucosal neuromas or marfanoid habitus, or elevated calcitonin levels suggesting medullary thyroid carcinoma. Early genetic diagnosis directs personalized cancer surveillance and preventive surgical planning.
2. How is the sample collected and what preparation is needed?
A certified phlebotomist collects a peripheral whole blood sample during a scheduled home visit. No fasting is required. A mandatory pre-test genetic counselling session must be completed before sample collection to document informed consent and family history. The sample is transported under temperature-controlled cold chain to our ISO-accredited laboratory.
3. What do my results mean and when will I receive them?
Your report will classify the finding as positive (disease-causing mutation detected), negative (no pathogenic variant identified), or a variant of uncertain significance. Positive results guide prophylactic thyroidectomy and annual pheochromocytoma screening. Results are issued within 3–4 weeks, followed by a telephonic consultation with a consultant medical genetics specialist to explain findings and next steps.
4. Will my insurance cover the cost of this genetic test?
Coverage varies by insurance provider and policy. Our team can verify your direct billing eligibility via WhatsApp at +971 54 548 8731. We recommend confirming coverage prior to scheduling the test. Self-pay option is available at 2,800 AED.
UAE Regulatory & Data Privacy Adherence
- Personal Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – all genetic data is encrypted, access-controlled, and processed solely for diagnostic purposes with explicit patient consent.
- Health Information Governance: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure electronic health record handling and data interoperability standards.
- Medical Liability Framework: Informed consent and clinical safety protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing patient rights and professional accountability.
- Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – routine internal and external quality audits ensure diagnostic reliability.
Clinical & Logistical Metadata
| Test Name | RET Gene Multiple Endocrine Neoplasia Type 2B (MEN2B) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Full-gene Next Generation Sequencing (NGS) |
| ICD-10-CM Code | E31.22 |
| LOINC Code | 21673-2 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians